Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Selective Increase in OC Symptoms is Driving Information Seeking and Guideline Adherence During the Covid-19 Pandemic

View ORCID ProfileAlisa M. Loosen, View ORCID ProfileVasilisa Skvortsova, View ORCID ProfileTobias U. Hauser
doi: https://doi.org/10.1101/2020.12.08.20245803
Alisa M. Loosen
1Max Planck UCL Centre for Computational Psychiatry and Ageing Research
2Wellcome Centre for Human Neuroimaging, University College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alisa M. Loosen
  • For correspondence: a.loosen.17{at}ucl.ac.uk t.hauser{at}ucl.ac.uk
Vasilisa Skvortsova
1Max Planck UCL Centre for Computational Psychiatry and Ageing Research
2Wellcome Centre for Human Neuroimaging, University College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vasilisa Skvortsova
Tobias U. Hauser
1Max Planck UCL Centre for Computational Psychiatry and Ageing Research
2Wellcome Centre for Human Neuroimaging, University College London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tobias U. Hauser
  • For correspondence: a.loosen.17{at}ucl.ac.uk t.hauser{at}ucl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Increased mental health problems as a reaction to stressful life events, such as the Covid-19 pandemic, are common. Critically, successful adaptation helps reduce such symptoms to baseline, preventing long-term psychiatric disorders. It is thus important to understand whether and which psychiatric symptoms only show transient elevations, and which persist long-term and become chronically heightened. At particular risk for the latter trajectory are disorders with symptoms directly affected by the pandemic, such as obsessive-compulsive disorder.

Methods In this longitudinal large-scale study (N=416), we assessed how obsessive-compulsive (OC), anxiety, and depression symptoms changed throughout the course of the first pandemic wave in a sample of the general UK public. We further examined how these symptoms affected pandemic-related information seeking and adherence to governmental guidelines.

Findings All psychiatric domains were initially elevated, but showed distinct adaptation patterns. Depression scores decreased during the first pandemic wave, however, OC symptoms further increased, even after the end of lockdown. These OC symptoms were directly linked to Covid-related information seeking which gave rise to higher adherence to government guidelines.

Interpretation The rise and persistence of OC symptoms, despite the ease of Covid-19 restrictions, shows that OCD is disproportionally and chronically affected by the pandemic. This is particularly worrying with regards to the long-term impact of the Covid-19 pandemic on public mental health and indicates that patients with OCD may require particular treatment efforts.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

A.M.L. is a pre-doctoral fellow of the International Max Planck Research School on Computational Methods in Psychiatry and Ageing Research (IMPRS COMP2PSYCH). The participating institutions are the Max Planck Institute for Human Development, Berlin, Germany, and University College London, London, UK. For more information, see: https://www.mps-ucl-centre.mpg.de/en/comp2psych T.U.H. is supported by a Sir Henry Dale Fellowship (211155/Z/18/Z) from Wellcome & Royal Society, a grant from the Jacobs Foundation (2017-1261-04), the Medical Research Foundation, and a 2018 NARSAD Young Investigator grant (27023) from the Brain & Behavior Research Foundation. T.U.H. is also supported by the European Research Council (ERC) under the Horizon 2020 research and innovation programme (grant agreement No 946055) of the European Union. V.S. received funding from the Horizon 2020 research and innovation programme of the European Union under the Marie Skłodowska-Curie grant agreement No 895213.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UCL Research Ethics Committee University College London 2 Taviton St, London WC1E 6BT

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Fully anonymised data for this study will be available from the corresponding authors upon reasonable request (a.loosen.17{at}ucl.ac.uk) with peer-reviewed publication. Simultaneously, code for data analysis will be available from a dedicated Github repository (https://github.com/DevComPsy).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 09, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Selective Increase in OC Symptoms is Driving Information Seeking and Guideline Adherence During the Covid-19 Pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Selective Increase in OC Symptoms is Driving Information Seeking and Guideline Adherence During the Covid-19 Pandemic
Alisa M. Loosen, Vasilisa Skvortsova, Tobias U. Hauser
medRxiv 2020.12.08.20245803; doi: https://doi.org/10.1101/2020.12.08.20245803
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Selective Increase in OC Symptoms is Driving Information Seeking and Guideline Adherence During the Covid-19 Pandemic
Alisa M. Loosen, Vasilisa Skvortsova, Tobias U. Hauser
medRxiv 2020.12.08.20245803; doi: https://doi.org/10.1101/2020.12.08.20245803

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)